Amanote Research

Amanote Research

    RegisterSign In

Inequalities in Non-Small Cell Lung Cancer Treatment and Mortality

Journal of Epidemiology and Community Health - United Kingdom
doi 10.1136/jech-2014-205309
Full Text
Open PDF
Abstract

Available in full text

Categories
EpidemiologyPublic HealthOccupational HealthEnvironmental
Date

June 5, 2015

Authors
Ula NurManuela QuaresmaBianca De StavolaMichael PeakeBernard Rachet
Publisher

BMJ


Related search

Afatinib Treatment in Advanced Non-Small Cell Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2011English

Individualization of Treatment in Non-Small Cell Lung Cancer

F1000 Medicine Reports
2009English

Diabetes Mellitus Increases Postoperative Mortality in Non-Small Cell Lung Cancer

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2014English

Latest Immunotherapy Methods in Non-Small Cell Lung Cancer Treatment

Juntendo Medical Journal
2019English

MA14.11 Factors Associated With Early Mortality in Non-Small Cell Lung Cancer Patients Following Systemic Anti-Cancer Treatment

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Bevacizumab in the Treatment of Non-Small-Cell Lung Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2007English

Innovations in the Treatment of Non-Small Cell Lung Cancer

English

Non-Small Cell Lung Cancer

English

On the Pharmacogenetics of Non-Small Cell Lung Cancer Treatment

Expert Opinion on Drug Metabolism and Toxicology
MedicineToxicologyPharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy